Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2006
03/29/2006EP1638578A2 Hydrolytically-resistant boron-containing therapeutics and methods of use
03/29/2006EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands
03/29/2006EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
03/29/2006EP1638400A2 Triazolopyrimidines
03/29/2006EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments
03/29/2006EP1036090B1 Echinocandin derivatives, preparation method and application as anti-fungal agents
03/29/2006CN1753896A Novel compounds and uses thereof
03/29/2006CN1753895A Spiro-substituted pyrrolopyrimidines
03/29/2006CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
03/29/2006CN1753849A Mono amine and diamine derivatives of cl-20
03/29/2006CN1752088A Medicinal composition containing timeazoamine ester
03/29/2006CN1247594C Bicyclic heteroaromatic compounds
03/29/2006CN1247588C Adenosine A2A receptor antagonists
03/29/2006CN1247587C Tert. alkylphenoxy substituted polycyclic compounds
03/29/2006CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
03/29/2006CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
03/29/2006CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
03/29/2006CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound
03/28/2006US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders
03/28/2006US7019132 Porphyrin derivatives
03/28/2006US7019053 Stabilizer mixtures
03/28/2006US7019001 Substituted benzothiazole amide derivatives
03/28/2006US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
03/28/2006US7018620 Delivery of beta-blockers through an inhalation route
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2006031461A2 Pyrrolidinyl groups for attaching conjugates to oligomeric compounds
03/23/2006WO2006030847A1 Novel bicyclic pyrazole derivative
03/23/2006WO2006030805A1 Triazole derivative or salt thereof
03/23/2006WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006WO2006004884A3 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
03/23/2006WO2005028434A3 Novel heterocyclic compounds as hsp90-inhibitors
03/23/2006US20060063934 Pyrazole compounds
03/23/2006US20060063926 Making 1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one drugs, via a Sonogashira coupling reaction and copper iodide-promoted indole formation; drugs made have use e.g. as chemosensitizing agents (e.g. to anticancer drugs), and against neurodegenerative diseases
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/23/2006US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/23/2006US20060063787 Condensed imidazole derivatives
03/23/2006US20060063785 Substituted pyrazolo[1,5-a] pyrimidines and process for making same
03/23/2006US20060063784 Method of using substituted pyrazolo [1,5-a] pyrimidines
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060063037 acts as a hole injection material, a hole transport material, a light emitting host, or a light emitting dopant in the organic light emitting device depending on the type of substituent
03/23/2006US20060062932 has optical properties with films that are significantly thinner
03/23/2006US20060060829 Contains tetrahydroxy- or tetraalkoxy-substituted phthalocyanine
03/23/2006CA2580627A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006CA2580409A1 Triazole derivative or salt thereof
03/23/2006CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols
03/23/2006CA2580033A1 Imidazole compound
03/23/2006CA2579923A1 Anti-parasitic and/or anti-viral and/or anti-microbial compositions
03/22/2006EP1637533A1 Substituted thiazolopyrimidines as analgetics
03/22/2006EP1637532A1 Fused pyrimidine derivative
03/22/2006EP1637531A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
03/22/2006EP1637529A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof
03/22/2006EP1636238A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents
03/22/2006EP1636236A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
03/22/2006EP1636235A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
03/22/2006EP1636234A1 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors
03/22/2006EP1636233A1 Cannabinoid receptor ligands and uses thereof
03/22/2006EP1636228A1 Novel pyridopyrazines and use thereof as kinase modulators
03/22/2006EP1636227A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity
03/22/2006EP1636225A2 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents
03/22/2006EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors
03/22/2006EP1636217A1 2-imidazo-benzothiazoles as adenosine receptor ligands
03/22/2006EP1635944A1 Method for increasing the cutting hardness of a molded body
03/22/2006EP1635641A2 Mitotic kinesin inhibitors
03/22/2006EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
03/22/2006EP1436296B1 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
03/22/2006EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
03/22/2006EP1404319B1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
03/22/2006EP1377586B1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
03/22/2006EP1244660B1 Methods and compositions for the treatment of pain
03/22/2006EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
03/22/2006CN1751050A Benzamide derivatives as oxytocin agonists and vasopressin antagonists
03/22/2006CN1751047A Triazole compounds useful in therapy
03/22/2006CN1751046A Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments
03/22/2006CN1751045A 6-(2-halogenphenyl)-triazolopyrimidines derivatives and their use as fungicide
03/22/2006CN1751041A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/22/2006CN1751025A Diamine derivatives
03/22/2006CN1246432C Ligand and complex for catalytically bleaching substrate
03/22/2006CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
03/22/2006CN1246295C Method and intermediate used for manufacturing antifolic
03/21/2006US7015224 7-Tert-butyl-3-(2-fluorophenyl)-6-(2H-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3b) pyridazine for the treatment of anxiety and convulsions
03/21/2006US7015222 Agricultural compositions
03/21/2006US7014841 Delivery of antiemetics through an inhalation route
03/21/2006US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits
03/21/2006US7014696 Compounds, compositions and uses
03/16/2006WO2006029153A2 Monocyclic anilide spirolactam cgrp receptor antagonists
03/16/2006WO2006029075A2 Fibrate compounds having ppar agonist activity
03/16/2006WO2006028977A2 Chiral spiro compounds and their use in asymmetric catalytic reactions
03/16/2006WO2006028239A1 Carbamoyl-substituted spiro derivative
03/16/2006WO2006027628A2 Naphthalimide derivatives as antiviral agents
03/16/2006WO2006027170A1 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same
03/16/2006WO2006017054A3 Tricyclic-heteroaryl compounds useful as kinase inhibitors
03/16/2006WO2005115399A3 Imidazopyrazines, imidazopyridines, ans imidazopyrimidines as crf1 receptor ligands
03/16/2006WO2005115361A3 Androgen receptor modulators and method of treating disease using the same
03/16/2006WO2005039486A3 Compounds and compositions as protein kinase inhibitors
03/16/2006WO2005016235A3 Combined use of impdh inhibitors with toll-like receptor agonists
03/16/2006WO2004050716A3 Preparation of metallotexaphyrins
03/16/2006US20060058324 4-Amino-5-phenyl-7-cyclohexyl-pyrrolo 2,3-d pyrimidine derivatives
03/16/2006US20060058320 [1,2,4] Triazolo[1,5-c]pyrimidine derivatives
03/16/2006US20060058304 Azaindole kinase inhibitors